Volume | 0 |
|
|||||
News | - |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Sorrento Therapeutics Inc | SRNE | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
0.3073 | 0.3073 |
Trades | Shares Traded | Average Volume |
---|---|---|
0 | 0 | - |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
- | 0 | US$ 0.3073 | USD |
Sorrento Therapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
US$ 169.41M | - | - | - | -29.56 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Sorrento Therapeutics News
Date | Time | Source | News Article |
---|---|---|---|
04/11/2023 | 08:31 | Edgar (US Regulatory) | Form 8-K - Current report |
28/10/2023 | 07:15 | Edgar (US Regulatory) | Form 8-K - Current report |
13/9/2023 | 11:51 | Edgar (US Regulatory) | Form 8-K - Current report |
29/8/2023 | 07:25 | Edgar (US Regulatory) | Form 8-K - Current report |
08/8/2023 | 06:15 | Edgar (US Regulatory) | Form NT 10-Q - Notification of inability to timely file Form.. |
01/8/2023 | 20:01 | Edgar (US Regulatory) | Form 8-K - Current report |
13/7/2023 | 20:26 | Edgar (US Regulatory) | Form 8-K - Current report |
05/6/2023 | 23:00 | GlobeNewswire Inc. | Shanghai Escugen Biotechnology Co., Ltd., a partner of.. |
Historical SRNE Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Year | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3 Years | 7.96 | 11.07 | 0.161 | 2.60 | 11,130,804 | -7.65 | -96.14% |
5 Years | 3.74 | 21.26 | 0.161 | 5.98 | 13,174,461 | -3.43 | -91.78% |